Screener
Wave Life Sciences WVE Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts receivable | 888 | 1,276 |
| Prepaid expenses | 12,121 | 8,395 |
| Other current assets | 3,897 | 3,075 |
| Total current assets | 507,508 | 614,814 |
| Long-term assets: | ||
| Property and equipment, net of accumulated depreciation of $50,819 and $49,522 as of June 30, 2026 and December 31, 2025, respectively | 6,833 | 7,405 |
| Operating lease right-of-use assets | 39,498 | 12,458 |
| Restricted cash | 3,815 | 3,806 |
Item 1. Financial Statements
FAQ
- What is Wave Life Sciences's total current assets?
- Wave Life Sciences (WVE) reported total current assets of $507.51M in Q2 2026.
- How has Wave Life Sciences's total current assets changed year-over-year?
- Wave Life Sciences's total current assets increased by 127.0% year-over-year, from $223.56M to $507.51M.
- What is the long-term trend for Wave Life Sciences's total current assets?
- Over 5 years (2020 to 2025), Wave Life Sciences's total current assets has grown at a 21.7% compound annual growth rate (CAGR), from $230.04M to $614.81M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Wave Life Sciences's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude